Enteral formulation designed for optimized nutrient absorption and wound healing
US5723446A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 17, 1996 |
| Grant date | Mar 3, 1998 |
| Priority date | — |
| Expiry date | Jul 17, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an enteral nutritional formulation that meets the nutrient requirements of intensive care patients who may have compromised absorption capacity. The present invention meets the unique nutrient needs of the patient that are generated due to tissue repair and healing requirements. To this end, in an embodiment the present invention provides a method for treating and/or providing nutritional support to intensive care patients comprising the steps of administering a therapeutically effective amount of a composition comprising: a protein source; a carbohydrate source; and a lipid source including a source of medium chain triglycerides, a source of omega-3 fatty acids, and a source of omega-6 fatty acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.